Edity Therapeutics ’s Post

"At M:M Bio we do not believe that early-stage, preclinical companies need CEO leadership." In this week's Ask the Experts Interview series, we hear from Zoë Johnson, the Chief Scientific & Development Officer at M:M Bio. She shares more about her background and the emergence of new business models to improve R&D productivity and efficiency. Read the full article here: https://lnkd.in/g4G-yq5e #biotech #lifescience #sejelas #asktheexperts #interviewseries

Conferences not only provide a platform for discussion amongst luminaries, but also, and more importantly, shine a light on the future leaders of the industry. The Biosimilar Workshop 2023 proved to be one of the most exciting spaces to witness innovative and bold research. This came in the form of poster presentations from capable minds from not just academia but also start-ups and industries. We hope the next conference will include even more entrepreneurs and pioneers who are sure to change the world one day! 💪 Ratnesh Jain | Prajakta Dandekar | Institute Of Chemical Technology | Nanomedicine Research Group, ICTMumbai | Jaidev Bhatt | Preeti Kaushik | TEJAL KHANNA | Vishakha Kurlawala | Anushka Chaudhari | #Innovation #Entrepreneurship #Biotechstartup #Pharmaceuticals #rnd #Biochemistry #Biosimilars #Leadership #GoaDiaries #Networking #BiosimilarWorkshop #BSW2023 #BiotechInnovations #BiologicsWorkshop2025 #LeadershipInBiotech #InnovationUnleashed

Hear, hear! As Jason Kelly demonstrates, the U.S. is still at the brink of a pivotal moment in #biotechnology's future. We began the #biotech revolution and should be the world's leading #bioeconomy for generations to come - but that only happens through smart, deliberate, and strategic investment and policy choices. The National Security Commission on Emerging Biotechnology (NSCEB) is driving action, but they can't do it alone - it takes an all of society, broad-based coalition ready to push for the resources needed to realize biotech's full potential.

New op-ed by National Security Commission on Emerging Biotechnology (NSCEB) Chair Jason Kelly on the importance of multi-stakeholder collaboration to capture the potential of a biotech-enabled future. "Lately the world is enraptured with AI and its potential to change our lives. AI transforms our digital world—the world of information. But changing lives and livelihoods requires transforming not just information but atoms: our physical world. Biotechnology, the most sophisticated manufacturing technology on the planet, offers a profoundly generative capacity to transform atoms into what we need the most to survive and thrive: food, medicines, materials, and more. We are in a pivotal moment for shaping this biotech-enabled future, and showing what United States leadership looks like and why it matters, and we need your help to ensure we get it right." Read more here 👇

💼 Bold View Capital is making bold investments in tomorrow’s biotech leaders. Visit Booth #800 at SynBioBeta 2025 and discover how they’re fueling the future of biotech innovation. Register today to connect with their team! #SynBioBeta #BiotechFundingFutures #BoldInvestmentsInScience #FutureOfBiotech

🧫 Biotech Booster is the national Dutch program to support commercialization of biotechnology findings. It does so in five thematic clusters. One of those clusters is Industrial Biotechnology & Production. Cornelis Mijnders, cluster manager at Delft University of Technology, oversees the development of biotech business cases. 🌱 Mijnders believes biotech will play an essential role in creating a more sustainable world. "Biomass is everywhere. The process of fermentation can be done even in space. So it is a very democratic technology and relatively easy accessible by all countries." Read the full interview with Mijnders here: https://lnkd.in/eZWbv4dN #biotechbooster #collaboration #biotech #startups

🔍 Discover how Tevogen Bio is reshaping transparency norms in the biotech industry. Dive into how clear communication builds investor trust, secures strategic partnerships, and sets a new standard. Curious how transparency can transform business landscapes? 🌍🧬 Tevogen’s strategy sheds light on creating openness. Could this be the key to stability amidst market uncertainty? Find out more in my latest deep dive on the innovative practices reshaping the heart of biotech! #Biotech #Innovation #Leadership

Yesterday Biotechnology Innovation Organization in partnership with Korn Ferry, released "Charting a Path to Inclusive Excellence for Biotechnology Companies". This survey assesses diversity, equity, and inclusion (#DEI) in the biotechnology industry. At the ongoing BIO International Convention, DEI is a prominent theme. Notably, sessions such as "Building and Sustaining an Inclusive Life Sciences Ecosystem" and "DEI Strategies for Startups: Building a Diverse Workforce from the Ground Up" are scheduled to address these issues directly. These sessions offer valuable insights and strategies for organizations aiming to enhance their DEI initiatives. These discussions at #BIO2024 align perfectly with the findings from the BIO & Korn Ferry survey, providing a platform for industry leaders to share best practices and collaborate on fostering a more inclusive biotech sector. For those attending the conference, these sessions present a prime opportunity to engage with DEI experts and bring actionable insights back to their organizations. The continued focus on DEI is crucial for driving innovation and ensuring the biotech industry reflects the diverse communities it serves. Read the full survey: https://bit.ly/4bY9iVI For more details on these sessions, visit the BIO 2024 program: https://bit.ly/3yHJ6QI

Check out what will be an engaging discussion to recap #jpm2024 and also keep your momentum going by learning about opportunities at the Biotechnology Innovation Organization CEO & Investor Conference!

In case you missed it over the bank holiday weekend - check out the #BioIntegrates2024 summary blog post featuring all of the highlights and insights from the event!